Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Two mouse mutations cause similar hair loss despite different skin changes.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Hair loss treatment caused more hair loss in a man.

ILC1 cells contribute to hair loss in alopecia areata.

Dandruff is linked to changes in the immune system of hair follicles and skin.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Skin bacteria can help wound healing by activating certain immune cells.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Hair follicles could help develop eye treatments by studying immune responses.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Hair follicles prevent NK cell attacks to avoid hair loss.

DM and AA may share a common cause.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Somatostatin may help protect hair follicles from immune attacks.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

UV light helped human hair transplants survive in mice without broad immunosuppression.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.